Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024
Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024
-
World Rank (Jan-05-2024)2,350Market Cap (Jan-05-2024)6.583 Billion USDWorld Rank (Jul-30-2023)2,721Market Cap (Jul-30-2023)5.524 Billion USDWorld Rank (Dec-25-2022)7,610Market Cap (Dec-25-2022)1.178 Billion USDWorld Rank (Jan-07-2022)5,962Market Cap (Jan-07-2022)2.16 Billion USDAnnual Revenue in USD77 Million USDAnnual Net Income in USD-481 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileBridgeBio Pharma is a biotechnology company that develop and deliver breakthrough medicines for genetic diseases to patients as quickly and safely as possible. The headquarters is in USA.Company Website
-
Vaxcyte Inc.
World Rank (Jan-05-2024)2,495Market Cap (Jan-05-2024)6.122 Billion USDWorld Rank (Jul-30-2023)3,324Market Cap (Jul-30-2023)4.376 Billion USDWorld Rank (Dec-25-2022)3,506Market Cap (Dec-25-2022)3.686 Billion USDWorld Rank (Jan-07-2022)8,241Market Cap (Jan-07-2022)1.26 Billion USDAnnual Revenue in USD0 Million USDAnnual Net Income in USD-223 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileVaxcyte is a Biotechnology company developing potentially superior and novel vaccines designed to prevent or treat the most common and deadly infectious diseases worldwide. It is having 43 employees as on 2019. The headquarters is in USA.
Company Website -
Immunovant
World Rank (Jan-05-2024)2,674Market Cap (Jan-05-2024)5.626 Billion USDWorld Rank (Jul-30-2023)4,418Market Cap (Jul-30-2023)2.942 Billion USDWorld Rank (Dec-25-2022)7,090Market Cap (Dec-25-2022)1.328 Billion USDWorld Rank (Jan-07-2022)9,880Market Cap (Jan-07-2022)0.92 Billion USDAnnual Revenue in USD0 Million USDAnnual Net Income in USD-156 Million USDAnnual Results for Period EndingMar-2022 ending yearCompany ProfileImmunovant is a Clinical Stage Biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The headquarters is in USA.Company Website -
Blueprint Medicines Corporation
World Rank (Jan-05-2024)2,761Market Cap (Jan-05-2024)5.394 Billion USDWorld Rank (Jul-30-2023)3,655Market Cap (Jul-30-2023)3.817 Billion USDWorld Rank (Dec-25-2022)4,493Market Cap (Dec-25-2022)2.642 Billion USDWorld Rank (Jan-07-2022)3,090Market Cap (Jan-07-2022)5.38 Billion USDAnnual Revenue in USD204 Million USDAnnual Net Income in USD-557 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileBio-pharmaceutical company with headquarters is in Massachusetts, USA.
Company Website -
ACADIA Pharmaceuticals
World Rank (Jan-05-2024)2,957Market Cap (Jan-05-2024)4.917 Billion USDWorld Rank (Jul-30-2023)3,125Market Cap (Jul-30-2023)4.723 Billion USDWorld Rank (Dec-25-2022)4,658Market Cap (Dec-25-2022)2.505 Billion USDWorld Rank (Jan-07-2022)4,217Market Cap (Jan-07-2022)3.63 Billion USDAnnual Revenue in USD517 Million USDAnnual Net Income in USD-215 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileAcadia Pharmaceuticals is a Healthcare and Pharmaceutical company. The company is of food and drug administration for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. Around 8 million people in the United States are living with dementia and studies suggest that approximately 30% of people with dementia, 2.4 million people, experience dementia-related hallucinations and delusion. The headquarters is in USA.
Company WebsiteWikipedia -
Alkermes
World Rank (Jan-05-2024)3,032Market Cap (Jan-05-2024)4.784 Billion USDWorld Rank (Jul-30-2023)3,088Market Cap (Jul-30-2023)4.778 Billion USDWorld Rank (Dec-25-2022)3,161Market Cap (Dec-25-2022)4.188 Billion USDWorld Rank (Jan-07-2022)3,992Market Cap (Jan-07-2022)3.88 Billion USDAnnual Revenue in USD1,111 Million USDAnnual Net Income in USD-158 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileAlkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. Headquarters is in Dublin, Ireland.
Alkermes seeks to develop innovative medicines that help address the unmet needs and challenges of people living with debilitating diseases.
The company has a portfolio of proprietary commercial products focused on addiction and schizophrenia, and a pipeline of product candidates in development for schizophrenia, bipolar I disorder, neurodegenerative disorders and cancer.
Company WebsiteWikipedia -
Nuvalent Inc.
World Rank (Jan-05-2024)3,133Market Cap (Jan-05-2024)4.610 Billion USDWorld Rank (Jul-30-2023)4,632Market Cap (Jul-30-2023)2.756 Billion USDWorld Rank (Dec-25-2022)6,273Market Cap (Dec-25-2022)1.605 Billion USDWorld Rank (Jan-07-2022)11,341Market Cap (Jan-07-2022)0.71 Billion USDAnnual Revenue in USD0 Million USDAnnual Net Income in USD-82 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileNuvalent, Inc., is a clinical stage biopharmaceutical company, and it develops therapies for patients with cancer.
The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts, USA.
Company Website -
Perrigo Company
World Rank (Jan-05-2024)3,172Market Cap (Jan-05-2024)4.552 Billion USDWorld Rank (Jul-30-2023)3,003Market Cap (Jul-30-2023)4.946 Billion USDWorld Rank (Dec-25-2022)3,011Market Cap (Dec-25-2022)4.446 Billion USDWorld Rank (Jan-07-2022)3,057Market Cap (Jan-07-2022)5.45 Billion USDAnnual Revenue in USD4,451 Million USDAnnual Net Income in USD-140 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfilePerrigo is a leading global healthcare company, focused on providing value to its customers and consumers by delivering Quality Affordable Healthcare Products. Perrigo has built a unique business model that is best described as the convergence of a fast-moving consumer goods company, a high-quality pharmaceutical manufacturing organization and a world-class supply chain network. Perrigo is the world's largest manufacturer of OTC healthcare products and supplier of infant formulas for the store brand market.Company WebsiteWikipedia -
Madrigal Pharmaceuticals
World Rank (Jan-05-2024)3,310Market Cap (Jan-05-2024)4.308 Billion USDWorld Rank (Jul-30-2023)3,701Market Cap (Jul-30-2023)3.759 Billion USDWorld Rank (Dec-25-2022)2,892Market Cap (Dec-25-2022)4.679 Billion USDWorld Rank (Jan-07-2022)8,034Market Cap (Jan-07-2022)1.32 Billion USDAnnual Revenue in USD0 Million USDAnnual Net Income in USD-295 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileMadrigal Pharmaceuticals is a Clinical Stage Biopharmaceutical company. It is pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver which is a key regulatory mechanism common to a spectrum of cardio metabolic and fatty liver diseases with high unmet medical need. The headquarters is in USA.
Company Website -
Insmed
World Rank (Jan-05-2024)3,388Market Cap (Jan-05-2024)4.167 Billion USDWorld Rank (Jul-30-2023)4,448Market Cap (Jul-30-2023)2.913 Billion USDWorld Rank (Dec-25-2022)4,526Market Cap (Dec-25-2022)2.621 Billion USDWorld Rank (Jan-07-2022)4,793Market Cap (Jan-07-2022)3.05 Billion USDAnnual Revenue in USD245 Million USDAnnual Net Income in USD-481 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileInsmed is a Biopharmaceutical company. The headquarters is in USA.
Company Website